does bcn cover glp-1 Navigating Changes to Medication Coverage Paving the way for expanded

Please note that these statements have not been evaluated by the Food and Drug Administration and this product is not intended to diagnose, treat, cure or prevent any disease

Wegovy is intended for use in adults with obesity (body mass index [BMI] of 30 kg/m or greater) or overweight individuals (BMI of 27 kg/m or greater) with at least one weight-related comorbidity, such as type 2 diabetes or high blood pressure

Traditional insurance often denies GLP-1 coverage for weight loss, limiting access to patients with Type 2 diabetes diagnoses

If we take binders too close to our glutathione supplement, the binder may bind to the glutathione, making it ineffective